- Federal government must find alternatives to rescheduling hydrocodone combination drugs
- Actavis launches generic version of Opana ER
- FDA to recommend rescheduling of opioid painkiller hydrocodone from CIII to CII
- Actavis seeks approval for generic opioid-dependence drug
- FDA issues sweeping new requirements for long-acting opioids
NORTH WALES, Pa. — Teva Pharmaceutical Industries has launched a generic opioid medication for treating pain, the company said.
Teva announced the introduction of oxymorphone hydrochloride tablets.
The drug is a generic version of Endo Pharmaceuticals' Opana and will be available in the 5 mg and 10 mg strengths in bottles of 100 tablets.